Back to top

Direct-to-Consumer Advertising (DTCA) for Pharmaceutical Products

Rainone, N., Oodal, R., & Niederdeppe, J. (2018). The (surprising) impact of televised antidepressant direct-to-consumer advertising on the stigmatization of mental illness. Community Mental Health Journal, 54(3), 267-275.

Niederdeppe, J., Avery, R. J., Kellogg, M., & Mathios, A. (2017). Mixed messages, mixed outcomes: Exposure to direct-to-consumer pharmaceutical advertising for statin drugs is associated with more frequent visits to fast food restaurants and exercise. Health Communication, 32, 845-856.

Kruger, C., Niederdeppe, J., Byrne, S., & Avery, R. (2015). Effects of exposure to direct-to-consumer television advertising for statin drugs on food and exercise guilt. Patient Education and Counseling, 98, 1150-1155

Niederdeppe, J., Byrne, S., Avery, R., & Cantor, J. (2013). Exposure to direct-to-consumer pharmaceutical advertising, diagnosis with high cholesterol, and statin use. Journal of General Internal Medicine, 28(7), 886-893.

Byrne, S., Niederdeppe, J., Avery, R., & Cantor, J. (2013). ‘When diet and exercise are not enough’: An examination of lifestyle change inefficacy claims in direct-to-consumer advertising. Health Communication, 28, 800-813.